Fractional CIO
Program Management
Biotech & Life Sciences
Biotech Companies Don't Fail at Launch Because of Bad Science. They Fail Because Their IT Wasn't Ready.
No IT leadership yet? As your fractional CIO, I own the full IT function -- commercial systems, data & analytics, enterprise infrastructure, compliance, security, and everything in between. From pre-commercial Phase 2/3 to global enterprise, across ultra-rare, rare disease, specialty, and primary care -- without the cost or delay of a full-time hire.
​
Scaling your IT organization? Your IT leader has the vision. I bring the specialized commercial launch experience to accelerate it. As a Program Manager embedded alongside your team, I own major initiatives -- commercial data platforms, CRM implementations, BI deployments, and systems integrations -- so your IT organization can deliver more, faster, without pulling focus from day-to-day operations.
Enterprise Experience. Biotech Speed.
With 25+ years building and running commercial IT for life sciences and biotech, our founder Patrick Retif served as Global Commercial CIO at Allergan, a $15B global pharmaceutical company -- leading 150 people across 75 markets and championing 20+ product launches. At IQVIA, he ran a $750M P&L with 2,000+ FTEs. Since founding Tailwinds Advisory, he has personally led or overseen 15+ biotech launches across rare disease, specialty, and primary care -- building the full commercial IT stack required to get to market and scale, including the commercial data and analytics platforms that most biotechs struggle to get right.
What We Deliver
What a CEO Said After Launch
"We needed to upgrade substantially our IT to support our first product launch but it was a challenge to find a seasoned permanent CIO. As our fractional CIO, Tailwinds Advisory Group, engaged with our business leaders, designed our IT solutions and budget, managed sourcing, and drove IT readiness for a very successful product launch.​In 9 months, we were fully operational and on budget after deploying a flexible and scalable IT organization and zero footprint cloud-based IT infrastructure solution"
Marco Taglietti, CEO of SCYNEXIS
The IT Leadership Dilemma in Biotech
Every month a biotech delays its drug launch costs $20M in lost revenue. Yet most pre-commercial companies reach Phase 3 without the IT leadership they need. This white paper explores why fractional CIOs are the strategic choice for biotech navigating Phase 3 to U.S. commercial launch.
15+ Product Launches Delivered
Led or overseen more than 15 biotech product launches across rare disease, specialty, and primary care — architecting the full commercial IT stack from CRM to data warehouse to analytics.
20+ Commercial Data Platforms Built
Data warehouses, MDM, ETL pipelines, data governance, and KPI frameworks -- designed and delivered from scratch on Snowflake, Azure, and SQL Server for biotech commercial teams that need a single source of truth.
Enterprise-Scale Track Record
Former Global Commercial CIO at Allergan, a $15B pharmaceutical company — leading 150 IT professionals across 75 markets. Former SVP & GM at IQVIA, running a $750M P&L with 2,000+ FTEs.
5 Aggregator Integrations
End-to-end onboarding of IQVIA, Symphony Health, Veeva Compass, and Komodo Health -- contract support, data mapping, quality validation, and refresh scheduling to power commercial analytics from day one.
One Proven Executive
You're not hiring a consulting firm that sends juniors. You're getting a senior executive who has done this at the highest level — embedded in your leadership team, accountable for results.
20+ Power BI Deployments
Executive dashboards, field sales reporting, Rx trending, market share, and patient journey analytics -- built in Power BI with governed data models and role-based access across biotech commercial organizations.
Frequently Asked Questions
What does a fractional CIO do for a biotech company?
A fractional CIO provides senior IT executive leadership on a part-time or project basis. For biotech and life sciences companies, this means owning the commercial IT strategy, overseeing CRM and data platform implementations, managing vendor relationships, driving launch readiness, and making CIO-level decisions -- without the overhead of a full-time executive hire. The Fractional CIO operates as an embedded member of your leadership team, not an outside advisor.
When does a biotech company need a fractional CIO?
The most common trigger is an upcoming U.S. product launch -- typically when a company is in late Phase 2 or Phase 3 and needs to start building the commercial IT infrastructure. Other triggers include implementing a CRM like Veeva, building a commercial data warehouse, standing up BI/analytics, or inheriting a broken IT organization after a leadership change. If your biotech needs CIO-level judgment now but can't wait 6 months for a full-time hire, a fractional CIO fills that gap immediately.
​
How does Tailwinds Advisory work alongside an existing IT leader?
Many of our engagements are alongside an existing IT leader. In these cases, we operate as a Program Manager -- owning a specific large-scale program such as a CRM rollout, data platform build, or launch-readiness initiative. Your IT leader stays focused on the broader business while we accelerate delivery of the program. It's not about replacing your team. It's about adding a senior executive with 25+ years of commercial IT experience to help your IT organization deliver more, faster.​
What's the difference between a fractional CIO and a Program Manager engagement?
A fractional CIO engagement means Tailwinds Advisory acts as your IT executive -- setting strategy, managing the budget, leading vendors, and making decisions across the full IT landscape. A Program Manager engagement is more targeted: Tailwinds Advisory takes ownership of a specific large program -- such as a commercial data platform build, a CRM implementation, or a launch-readiness initiative -- and drives it from strategy through delivery. Some clients start with a program engagement and expand to fractional CIO. Others only need a program delivered.
What commercial data & analytics programs does Tailwinds Advisory deliver?
We build the full commercial data platform: data warehouse architecture, master data management (MDM), third-party data aggregator integration (IQVIA, Symphony Health, Veeva Compass, Komodo), tokenization frameworks, Power BI dashboards, KPI definition, and reporting automation. Whether you need a data strategy from scratch or need to fix a platform that isn't delivering insights, we own the program end-to-end.
​
How long does a typical engagement last?
It depends on the scope. A fractional CIO launch engagement typically runs 12-18 months, starting well before FDA approval and continuing through commercial readiness. A data platform build or CRM implementation may run 6-9 months. Some clients retain Tailwinds Advisory on an ongoing basis for strategic IT oversight. Every engagement is scoped to what the business needs -- and many clients extend as priorities evolve.
​